カテゴリー： DelveInsight, 薬APIインサイト2016

Zelboraf：医薬品の世界市場2016

DelveInsightが発行した調査報告書（DIDR2016287）
◆英語タイトル：Zelboraf -Drug Insights, 2016
◆商品コード：DIDR2016287
◆発行会社（リサーチ会社）：DelveInsight
◆発行日：2016年版（※最新版はお問い合わせください）
◆ページ数：35以上
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：製薬
◆販売価格オプション（消費税別）
Single User（1名使用）USD1,000 ⇒換算￥109,000見積依頼/購入/質問フォーム
Site Price（同一国内共有可）USD2,000 ⇒換算￥218,000見積依頼/購入/質問フォーム
Enterprise Price（複数国内共有可）USD3,000 ⇒換算￥327,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、Zelboraf（医薬品）の世界市場について調査・分析し、以下の構成でお届けいたします。

・Zelboraf薬剤の概要
・Zelboraf薬剤の世界市場規模（販売量予測）
・Zelboraf薬剤の説明：作用機序（MOA）、薬力学的特性、薬物動態学的特性
・Zelboraf薬剤の市販状況：アメリカ、ヨーロッパ
・Zelboraf薬剤の特許情報、特許権及び独占権存続期間
・Zelboraf薬剤のグローバルAPI（医薬品原薬）メーカー：地域別分析（アメリカ、ヨーロッパ、中国）
・関連企業分析
【レポートの概要】

DelveInsight Drug Report, “Zelboraf- Drug Insights, 2016” highlights the Zelboraf marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Zelboraf covering the total sales estimation and also provides the Zelboraf sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Zelboraf, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Zelboraf.
Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.


Scope
• A review of the Zelboraf based on information derived from company and industry-specific sources
• Coverage of the Marketed data of the Zelboraf on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Zelboraf with location details
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Global Forecasted Sales Figure to 2018
• Qualitative and quantitative assessment of market space
• SWOT Analysis


【レポートの目次】

Table of Contents

1. DelveInsight Report Introduction
2. Zelboraf Overview
2.1 Market Competition
2.3 Competitors in Development
3 Global Sales Assessment
3.1 Historical Sales of Somavert
3.2 Forecasted Sales of Somavert
4 Product Description
4.1 Mechanism of Action
4.2 Pharmacodynamic Properties
4.3 Pharmacokinetic Properties
5 Marketed Details
5.1 United States
5.2 Europe
6 Patent Information
6.1 Patent Numbers and Expiry Details
6.2 Patent and Exclusivity Expiry Assessment United States (US)
6.3 Patent Details
7 Route of Synthesis
8 Global API Manufacturers Assessment
8.1 The United States Drug Master File (US DMF)
8.2 The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
8.3 The Active Pharmaceutical Ingredient (API) Manufacturers in China
8.4 The Active Pharmaceutical Ingredient (API) Manufacturers in India
9 Generic Players
10 The Pipeline Coverage
11 Clinical Trials Information
11.1 Clinical Trials by Zone
12 Company Profile
12.1 Company Summary
12.2 Company Financials
13 SWOT Analysis
14 References
15 Appendix
16 Methodology
17 Consulting Services
18 About DelveInsight
19 Contact Us
20 Disclaimer

List of Tables
• Table 1: Zelboraf, Historical Global Sales (in million USD), 2016
• Table 2: Zelboraf, Forecasted Global Sales (in million USD), 2016
• Table 3: Zelboraf, Description
• Table 4: Zelboraf, Marketed Details the United States (US)
• Table 5: Zelboraf, Marketed Details the Europe (EU)
• Table 6: Zelboraf, Patent/Exclusivity Expiry (Year), 2016
• Table 7: Zelboraf, Patent Number Specific Patent Expiry (Year), 2016
• Table 8: Zelboraf, Patent Details
• Table 9: Zelboraf, Route of Synthesis
• Table 10: Zelboraf, the United States Drug Master File (US DMF), 2016
• Table 11: Zelboraf, the Europe Active Substance Master File (ASMF), 2016
• Table 12: Zelboraf, the API Manufacturers, China, 2016
• Table 13: Zelboraf, the API Manufacturers, India, 2016
• Table 14: Zelboraf, Generic Players, 2016
• Table 15: Zelboraf, Pipeline Drug Details, 2016
• Table 16: Zelboraf, Clinical Trials, 2016
• Table 17: Zelboraf, Clinical Trials by Zone, 2016
• Table 18: Company Overview, 2016
• Table 19: Zelboraf, SWOT Analysis, 2016


List of Figures
• Figure 1: Zelboraf, Historical Global Sales (in million USD), 2016
• Figure 2: Zelboraf, Forecasted Global Sales (in million USD), 2016
• Figure 3: Zelboraf, Patent/Exclusivity Expiry (Year), 2016
• Figure 4: Zelboraf, Patent Number Specific Patent Expiry (Year), 2016
• Figure 5: Zelboraf, Route of synthesis
• Figure 6: Zelboraf, the API Manufacturers by the US DMF Status (%), 2016
• Figure 7: Zelboraf, the API Manufacturers by Region, 2016
• Figure 8: Zelboraf, the API Manufacturers by Location/Countries, 2016
• Figure 9: Zelboraf, Generic Players, 2016
• Figure 10: Zelboraf, Clinical Trials by Zone (%), 2016


【レポートのキーワード】

Zelboraf、医薬品、薬剤、特許、販売量、市場規模、原薬メーカー

【免責事項】
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ Zelboraf：医薬品の世界市場2016(Zelboraf -Drug Insights, 2016)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • Zyvoxid：医薬品の世界市場2016 DelveInsight Drug Report, “Zyvoxid- Drug Insights, 2016” highlights the Zyvoxid marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Zyvoxid covering the total sales estimation and also provides the Zyvoxid sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Zyvoxid, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Zyvoxid. Please note:This report requires certain updates. We have all...
  • Vpriv：医薬品の世界市場2016 DelveInsight Drug Report, “Vpriv- Drug Insights, 2016” highlights the Vpriv marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Vpriv covering the total sales estimation and also provides the Vpriv sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Vpriv, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Vpriv. Please note:This report requires certain updates. We have all...
  • Tyvaso：医薬品の世界市場2016 DelveInsight Drug Report, “Tyvaso- Drug Insights, 2016” highlights the Tyvaso marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Tyvaso covering the total sales estimation and also provides the Tyvaso sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Tyvaso, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Tyvaso. Please note:This report requires certain updates. We have all...
  • Synagis：医薬品の世界市場2016 DelveInsight Drug Report, “Synagis- Drug Insights, 2016” highlights the Synagis marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Synagis covering the total sales estimation and also provides the Synagis sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Synagis, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Synagis. Please note:This report requires certain updates. We have all...
  • Risperdal Consta LP：医薬品の世界市場2016 DelveInsight Drug Report, “Risperdal Consta LP- Drug Insights, 2016” highlights the Risperdal Consta LP marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Risperdal Consta LP covering the total sales estimation and also provides the Risperdal Consta LP sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Risperdal Consta LP, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the...
  • Provenge：医薬品の世界市場2016 DelveInsight Drug Report, “Provenge- Drug Insights, 2016” highlights the Provenge marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Provenge covering the total sales estimation and also provides the Provenge sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Provenge, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Provenge. Please note:This report requires certain updates. We have all...
  • Pentasa Enema：医薬品の世界市場2016 DelveInsight Drug Report, “Pentasa Enema- Drug Insights, 2016” highlights the Pentasa Enema marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Pentasa Enema covering the total sales estimation and also provides the Pentasa Enema sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Pentasa Enema, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Pentasa Enema. Please note:This report...
  • Nexium-Mups：医薬品の世界市場2016 DelveInsight Drug Report, “Nexium-Mups- Drug Insights, 2016” highlights the Nexium-Mups marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Nexium-Mups covering the total sales estimation and also provides the Nexium-Mups sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Nexium-Mups, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Nexium-Mups. Please note:This report requires certain updates. We have all...
  • Multaq：医薬品の世界市場2016 DelveInsight Drug Report, “Multaq- Drug Insights, 2016” highlights the Multaq marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Multaq covering the total sales estimation and also provides the Multaq sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Multaq, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Multaq. Please note:This report requires certain updates. We have all...
  • Kivexa：医薬品の世界市場2016 DelveInsight Drug Report, “Kivexa- Drug Insights, 2016” highlights the Kivexa marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Kivexa covering the total sales estimation and also provides the Kivexa sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Kivexa, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Kivexa. Please note:This report requires certain updates. We have all...
  • Imprida：医薬品の世界市場2016 DelveInsight Drug Report, “Imprida- Drug Insights, 2016” highlights the Imprida marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Imprida covering the total sales estimation and also provides the Imprida sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Imprida, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Imprida. Please note:This report requires certain updates. We have all...
  • Fazlodeks：医薬品の世界市場2016 DelveInsight Drug Report, “Fazlodeks- Drug Insights, 2016” highlights the Fazlodeks marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Fazlodeks covering the total sales estimation and also provides the Fazlodeks sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Fazlodeks, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Fazlodeks. Please note:This report requires certain updates. We have all...
  • Dysport：医薬品の世界市場2016 DelveInsight Drug Report, “Dysport- Drug Insights, 2016” highlights the Dysport marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Dysport covering the total sales estimation and also provides the Dysport sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Dysport, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Dysport. Please note:This report requires certain updates. We have all...
  • Boostrix：医薬品の世界市場2016 DelveInsight Drug Report, “Boostrix- Drug Insights, 2016” highlights the Boostrix marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Boostrix covering the total sales estimation and also provides the Boostrix sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Boostrix, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Boostrix. Please note:This report requires certain updates. We have all...
  • Arranon：医薬品の世界市場2016 DelveInsight Drug Report, “Arranon- Drug Insights, 2016” highlights the Arranon marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Arranon covering the total sales estimation and also provides the Arranon sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Arranon, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Arranon. Please note:This report requires certain updates. We have all...
    • ◆H&Iグローバルリサーチのお客様（例）◆